Girard Frederic

Girard Frederic has a diverse work experience spanning several companies and roles. Girard currently holds the position of Senior Vice President, Commercial Operations Europe at DBV Technologies, where they are involved in the development of an investigational immunotherapy treatment for food allergies.

In addition, Girard Frederic is a member of the Strategic Committee of NovSanté Healthcare Fund at Eurazeo. This fund focuses on investments in French and European SMEs.

Prior to these roles, they served as CEO Sandoz France at Novartis and held the position of Executive Director, Franchise Primary Care, Novartis France. Girard also worked as the Managing Director of Gibaud Group at Össur.

Girard Frederic has further experience as the Managing Partner and Founder of Apteka Consulting, Marketing Company President, Russia at AstraZeneca, Chief Executive Officer, UK at Servier, and General Manager in Russia and Slovakia at Servier. Girard also served as the Deputy Regional Operations Manager, Central Europe at Servier.

Before joining Servier, Girard Frederic worked as the Group Products Manager at Boehringer Ingelheim and as a Line Manager at SmithKline Beecham.

Overall, Girard Frederic has demonstrated a strong background in the pharmaceutical and biopharmaceutical industry with extensive experience in leadership and commercial operations.

Girard Frederic attended Medical School, Lille from 1984 to 1992, where they earned a Doctor of Medicine (MD) degree in the field of Medicine. Additionally, they also pursued a DESS degree in Management at IAE, Lille from 1990 to 1992.